🏅 FDA Orphan Designation

Detectnet

copper Cu 64 dotatate

Manufacturer: RadioMedix Inc.

Indicated for:

Hereditary neuroendocrine tumor of small intestineSerotonin-producing neuroendocrine tumor of pancreas

FDA-Approved Indications (2)

Hereditary neuroendocrine tumor of small intestine

indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients

Population: adults

Serotonin-producing neuroendocrine tumor of pancreas

indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients

Population: adults

Indications & Usage

1 INDICATIONS AND USAGE Detectnet is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients. Detectnet is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients. ( 1 )

💙 Support Programs

View all →

Detectnet

RadioMedix Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.